These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6275254)

  • 1. "Battered data"--some clinical effects of the abuse of multiple regression methods: a second look at some observations on Ro07-0582 (Misonidazole).
    Herbert DE
    Med Phys; 1981; 8(6):848-64. PubMed ID: 6275254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of misonidazole in the United States.
    Wasserman TH; Stetz J; Phillips TL
    Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole in the clinic at Mount Vernon.
    Dische S
    Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
    Schwade JG; Makuch RW; Strong JM; Glatstein E
    Cancer Treat Rep; 1982 Sep; 66(9):1743-50. PubMed ID: 6288238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
    Bataini JP; Bernier J; de Narbonne J; Brugère J; Jaulerry C; Brunin F
    Bull Cancer; 1978; 65(4):482-5. PubMed ID: 371710
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
    Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma concentration of misonidazole and peripheral neuropathy.
    Marten TR
    Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
    [No Abstract]   [Full Text] [Related]  

  • 9. The neurotoxicity of misonidazole: pooling of data from five centres.
    Disch S; Saunders MI; Anderson P; Urtasun RC; Karcher KH; Kogelnik HD; Bleehen N; Phillips TL; Wasserman TH
    Br J Radiol; 1978 Dec; 51(612):1023-4. PubMed ID: 216455
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypoxic cell radiosensitizers--present and future.
    Wasserman TH
    Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):849-52. PubMed ID: 6457019
    [No Abstract]   [Full Text] [Related]  

  • 11. [New aspects of radiotherapy. I. Significance of hypoxia in irradiation of solid tumors].
    Overgaard J
    Ugeskr Laeger; 1979 Apr; 141(15):1006-11. PubMed ID: 442227
    [No Abstract]   [Full Text] [Related]  

  • 12. High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.
    Urtasun RC; Tanasichuk H; Fulton D; Agboola O; Turner AR; Koziol D; Raleigh J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):365-9. PubMed ID: 7107353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a hypoxic cell sensitizer on cancer radiotherapy: an analysis by a model.
    Okumura Y; Okajima S
    Strahlentherapie; 1984 Oct; 160(10):620-3. PubMed ID: 6495356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
    Walker MD; Strike TA
    Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on radiotherapy in combination with misonidazole].
    Ono K; Takahashi M; Dodo Y; Abe M
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1189-99. PubMed ID: 6663172
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation sensitization studies in Japan.
    Sugahara T; Nakatsugawa S
    Cancer Treat Rev; 1981 Mar; 8(1):51-61. PubMed ID: 7018682
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
    Bamberg M; Tamulevicius P; Streffer C; Scherer E
    Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing of hypoxic cell radiosensitizers in vivo.
    Denekamp J
    Cancer Clin Trials; 1980; 3(2):139-48. PubMed ID: 7428137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New side effect of the hypoxic cell sensitizer, misonidazole.
    Partington J; Koziol D; Chapman D; Rabin H; Urtasun RC
    Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer.
    Wasserman TH; Phillips TL; Johnson RJ; Gomer CJ; Lawrence GA; Sadee W; Marques RA; Levin VA; VanRaalte G
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):775-86. PubMed ID: 227821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.